Michigan Medicine increased research output during pandemic year

Author | Kelly Malcom

In early 2020, as Michigan Medicine faculty, learners and staff turned their attention to halting the spread of COVID-19 and providing much-needed care for patients, they also ramped up research efforts to include studies dedicated to understanding the novel coronavirus, SARS-CoV2 and the effects of COVID-19.

As a result, even with a brief pause in research activities, Michigan Medicine saw an increase in research awards in FY 2021 to $720 million, up from $662 million last year. $138 million of those awards came from industry collaboration, representing an investment into diversifying support for biomedical research efforts and moving fundamental discoveries into real-world practice more quickly.

“There is much reason for optimism, as our research at Michigan Medicine continues to impress and make a positive impact,” said Steven Kunkel, Ph.D., Executive Vice Dean for Research and Chief Scientific Officer for Michigan Medicine.

Overall, Michigan Medicine accounts for approximately 42 percent of the research volume for the University of Michigan. U-M’s academic medical center ranked tenth for NIH-funding for federal fiscal year 2020.

“Our research community has remained highly productive and innovative throughout the pandemic, continuing to bring new discoveries to light that impact health care and care delivery at Michigan Medicine. The pandemic has highlighted even more significantly the value ad importance of research in addressing the constantly evolving needs of our patients and the health care industry,” said Marschall Runge, M.D., Ph.D., Dean of the University of Michigan Medical School and CEO of Michigan Medicine.

Michigan Medicine researchers generated nearly 9,000 publications during calendar year 2020, ranking the number three healthcare institution for high-quality research in the world. These studies explored a range of scientific questions—from using high-throughput sequencing to develop images of genetic expression, to exploring how bias can affect the accuracy of pulse oximetry, to the optimization of telehealth to expand access to healthcare during the pandemic and beyond.

View the full FY2021 Michigan Medicine Research Annual Report
Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Featured News & Stories Illustration of a microscope
Health Lab
Researchers uncover distinct molecular subgroups of kidney disease for personalized treatment
Researchers have used advanced computer algorithms to uncover distinct molecular subgroups of kidney diseases, independent of clinical classifications. These findings have significant implications for personalized treatment approaches.
 infertilityawareness_Morrisons
Health Lab
Nurse shares IVF journey that led to her son
Malinda and David Morrison III welcomed their son in 2022 after years of trying to conceive
 Illustration of doctor pictured outside a pill bottle that houses a bent-over figure with pills lying on the ground
Health Lab
It’s easier now to treat opioid addiction with medication -- but use has changed little
Buprenorphine prescribing for opioid addiction used to require a special waiver from the federal government, but a new study shows what happened in the first year after that requirement was lifted.
Health Lab
Young heart transplant recipient fights off cancer
Young heart transplant recipient develops post-transplant lymphoma, but perseveres
 Moving illustration of family at the dinner table eating healthy diet
Health Lab
Playing short order cook, forcing clean plates may sabotage healthy eating habits in kids
While most parents of preschool and elementary aged children strive to give their children a balanced, nutritional diet, some of their strategies to promote healthy eating may backfire.
 Pill capsule pushing through a paper with amoxicillin printed on it.
Health Lab
Rise seen in use of antibiotics for conditions they can’t treat – including COVID-19
Overuse of antibiotics can lead bacteria to evolve antimicrobial resistance, but Americans are still receiving the drugs for many conditions that they can’t treat.